GL1X · GenesisL1 explorer

Research workbench

Ternary complex of human pancreatic glucokinase crystallized with activator, glucose and AMP-pnp

Analyse Ternary complex of human pancreatic glucokinase crystallized with activator… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ID8
Type
protein
Length
450 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glucokinase
EC
2.7.1.2
UniProt
P35557
Ligands
MRK, ANP, GLC, MG, K
Pockets
5 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlucokinase (EC 2.7.1.2)protein45046% helix, 21% strandP35557

Ligands and binding sites

  • MRK · 2-amino-4-fluoro-5-[(1-methyl-1H-imidazol-2-yl)sulfanyl]-N-(1,3-thiazol-2-yl)benzamide · ligand · chains A
  • ANP · Phosphoaminophosphonic acid-adenylate ester · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A
  • MG · Magnesium ion · metal · chains A
  • K · Potassium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12930.630.8138GLC, ANP, MG
21880.590.8124MRK
31010.360.7423ANP
4600.350.7816empty
5670.330.7613empty

Compared structures

  • 3ID8 · Ternary complex of human pancreatic glucokinase crystallized with activator, glucose and… · the same entry in another collection · chain A against A, TM-score 1.00
  • P35557 · AlphaFold monomer V2.0 prediction for hexokinase-4 (P35557) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.